A 64-year-old woman with symptomatic PAD and diabetes asks about antiplatelet therapy if rivaroxaban 2.5 mg BID is not chosen. Which single antiplatel...

Question

A 64-year-old woman with symptomatic PAD and diabetes asks about antiplatelet therapy if rivaroxaban 2.5 mg BID is not chosen. Which single antiplatelet is acceptable?

Accepted Answer

Clopidogrel 75 mg daily

Answer

Aspirin 325 mg daily

Answer

Aspirin 81 mg daily

Answer

Prasugrel 10 mg daily

Answer

Ticagrelor 90 mg BID

us-abim MCQ (SBA): Peripheral Artery Disease

A 64-year-old woman with symptomatic PAD and diabetes asks about antiplatelet therapy if rivaroxaban 2.5 mg BID is not chosen. Which single antiplatelet is acceptable?